Wells: Vaccine will be in the country by end of the week

Minister of Health Renward Wells.

As of Tuesday, February 23, 2021

MINISTER of Health Renward Wells says the Oxford-AstraZeneca vaccine will be in the country by the end of this week.

He said the roll out of jabs could start “as early as next week” but he will leave the announcement about the details to Prime Minister Dr Hubert Minnis.

“We’re looking at sort of the end of the week as was intimated by the deputy prime minister. . .it is good news,” Mr Wells said before heading into a Cabinet meeting on Tuesday. “What would make it even better news is when the vaccine lands, that the Bahamian people avail themselves of it to the maximum possible use. We want the Bahamian people vaccinated because we want our economy open, we want the Bahamian people safe.”

On Sunday, Dr Minnis made a strong appeal for all citizens to take the COVID-19 vaccine, insisting the country’s economic rebound hinged on widespread administration of the jab.

In a nationally televised address, Dr Minnis said when a large percentage of Bahamians are vaccinated, more of the country will be able to open up, adding this would spark more jobs among other economic positives.

For more on this story, see Wednesday’s Tribune.

More like this story

bahamianson 3 years, 8 months ago

the " roll out of jabs", wow, why are we parrots? we have never referred to needle sticks as jabs. let us do it our way. imagine telling a child or adult that ', we have to jab you , now". that is archaic talk not modern day civility

DDK 3 years, 8 months ago

11th December, 2020 BBC NEWS

"A promising Australian candidate for a coronavirus vaccine has been abandoned after trial participants returned false HIV positive results.

Australia had previously agreed to buy 51 million doses of the vaccine being developed by Australian firm CSL and the University of Queensland (UQ).

The government said orders of other vaccines would now fill the shortfall.

CSL and UQ stressed that the positive results were false - meaning trial participants' health was not at risk."

DDK 3 years, 8 months ago

"Oxford–AstraZeneca COVID-19 vaccine From Wikipedia, the free encyclopedia: 2020 development In February 2020, the Jenner Institute agreed a collaboration with the Italian company Advent Srl for the production of the first batch of a vaccine candidate for clinical trials.[25]

In March 2020,[26][27] after the Gates Foundation urged the University of Oxford to find a large company partner to get its COVID-19 vaccine to market, the university backed off from its earlier pledge to donate the rights to any drugmaker.[28] Also, the UK government encouraged the University of Oxford to work with AstraZeneca instead of Merck & Co., a US based company over fears of vaccine hoarding under the Trump administration.[29]

In June 2020, the US National Institute of Allergy and Infectious Diseases (NIAID) confirmed that the third phase of testing for potential vaccines developed by Oxford University and AstraZeneca would begin in July 2020.[30]

Clinical trials In July 2020, AstraZeneca partnered with IQVIA to speed up US clinical trials.[31]

On 31 August 2020, AstraZeneca announced that it had begun enrolling adults for a US-funded, 30,000-subject late-stage study.[32]

On 8 September 2020, AstraZeneca announced a global halt to the vaccine trial while a possible adverse reaction in a participant in the United Kingdom was investigated.[33][34][35] On 13 September, AstraZeneca and the University of Oxford resumed clinical trials in the United Kingdom after regulators concluded it was safe to do so.[36] AstraZeneca was criticised for vaccine safety after concerns from experts noting the company's refusal to provide details about serious neurological illnesses in two participants who received the experimental vaccine in Britain.[37] While the trial resumed in the UK, Brazil, South Africa, Japan[38] and India, it remained on pause in the US till 23 October 2020[39] while the Food and Drug Administration (FDA) investigated a patient illness that triggered the clinical hold, according to the United States Department of Health and Human Services (HHS) Secretary Alex Azar.[40]

On 15 October 2020, Dr João Pedro R. Feitosa, a 28-year-old doctor from Rio de Janeiro, Brazil, who received a placebo instead of the test vaccine in a clinical trial of AZD1222, died from COVID-19 complications.[41][42][43] The Brazilian health authority Anvisa announced that the trial would continue in Brazil.[44]"

A RUSHED VACCINE IF EVER THERE WAS ONE!